Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer

Rosario I. Corona; Ji Heui Seo; Xianzhi Lin; Dennis J. Hazelett; Jessica Reddy; Marcos A.S. Fonseca; Forough Abassi; Yvonne G. Lin; Paulette Y. Mhawech-Fauceglia; Sohrab P. Shah; David G. Huntsman; Alexander Gusev; Beth Y. Karlan; Benjamin P. Berman; Matthew L. Freedman; Simon A. Gayther; Kate Lawrenson

doi:10.1038/s41467-020-15951-0

Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer

Rosario I. Corona, Ji Heui Seo, Xianzhi Lin, Dennis J. Hazelett, Jessica Reddy, Marcos A.S. Fonseca, Forough Abassi, Yvonne G. Lin, Paulette Y. Mhawech-Fauceglia, Sohrab P. Shah, David G. Huntsman, Alexander Gusev, Beth Y. Karlan, Benjamin P. Berman, Matthew L. Freedman, Simon A. Gayther^*, Kate Lawrenson

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Abstract

The functional consequences of somatic non-coding mutations in ovarian cancer (OC) are unknown. To identify regulatory elements (RE) and genes perturbed by acquired non-coding variants, here we establish epigenomic and transcriptomic landscapes of primary OCs using H3K27ac ChIP-seq and RNA-seq, and then integrate these with whole genome sequencing data from 232 OCs. We identify 25 frequently mutated regulatory elements, including an enhancer at 6p22.1 which associates with differential expression of ZSCAN16 (P = 6.6 × 10-4) and ZSCAN12 (P = 0.02). CRISPR/Cas9 knockout of this enhancer induces downregulation of both genes. Globally, there is an enrichment of single nucleotide variants in active binding sites for TEAD4 (P = 6 × 10-11) and its binding partner PAX8 (P = 2×10-10), a known lineage-specific transcription factor in OC. In addition, the collection of cis REs associated with PAX8 comprise the most frequently mutated set of enhancers in OC (P = 0.003). These data indicate that non-coding somatic mutations disrupt the PAX8 transcriptional network during OC development.

Original language	English
Article number	2020
Journal	Nature Communications
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/s41467-020-15951-0
State	Published - 1 Dec 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41467-020-15951-0

Cite this

Corona, R. I., Seo, J. H., Lin, X., Hazelett, D. J., Reddy, J., Fonseca, M. A. S., Abassi, F., Lin, Y. G., Mhawech-Fauceglia, P. Y., Shah, S. P., Huntsman, D. G., Gusev, A., Karlan, B. Y., Berman, B. P., Freedman, M. L., Gayther, S. A., & Lawrenson, K. (2020). Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer. Nature Communications, 11(1), Article 2020. https://doi.org/10.1038/s41467-020-15951-0

@article{092ce62ca3964d33aef4cb955422405b,

title = "Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer",

abstract = "The functional consequences of somatic non-coding mutations in ovarian cancer (OC) are unknown. To identify regulatory elements (RE) and genes perturbed by acquired non-coding variants, here we establish epigenomic and transcriptomic landscapes of primary OCs using H3K27ac ChIP-seq and RNA-seq, and then integrate these with whole genome sequencing data from 232 OCs. We identify 25 frequently mutated regulatory elements, including an enhancer at 6p22.1 which associates with differential expression of ZSCAN16 (P = 6.6 × 10-4) and ZSCAN12 (P = 0.02). CRISPR/Cas9 knockout of this enhancer induces downregulation of both genes. Globally, there is an enrichment of single nucleotide variants in active binding sites for TEAD4 (P = 6 × 10-11) and its binding partner PAX8 (P = 2×10-10), a known lineage-specific transcription factor in OC. In addition, the collection of cis REs associated with PAX8 comprise the most frequently mutated set of enhancers in OC (P = 0.003). These data indicate that non-coding somatic mutations disrupt the PAX8 transcriptional network during OC development.",

author = "Corona, {Rosario I.} and Seo, {Ji Heui} and Xianzhi Lin and Hazelett, {Dennis J.} and Jessica Reddy and Fonseca, {Marcos A.S.} and Forough Abassi and Lin, {Yvonne G.} and Mhawech-Fauceglia, {Paulette Y.} and Shah, {Sohrab P.} and Huntsman, {David G.} and Alexander Gusev and Karlan, {Beth Y.} and Berman, {Benjamin P.} and Freedman, {Matthew L.} and Gayther, {Simon A.} and Kate Lawrenson",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41467-020-15951-0",

language = "אנגלית",

volume = "11",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

Corona, RI, Seo, JH, Lin, X, Hazelett, DJ, Reddy, J, Fonseca, MAS, Abassi, F, Lin, YG, Mhawech-Fauceglia, PY, Shah, SP, Huntsman, DG, Gusev, A, Karlan, BY, Berman, BP, Freedman, ML, Gayther, SA & Lawrenson, K 2020, 'Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer', Nature Communications, vol. 11, no. 1, 2020. https://doi.org/10.1038/s41467-020-15951-0

TY - JOUR

T1 - Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer

AU - Corona, Rosario I.

AU - Seo, Ji Heui

AU - Lin, Xianzhi

AU - Hazelett, Dennis J.

AU - Reddy, Jessica

AU - Fonseca, Marcos A.S.

AU - Abassi, Forough

AU - Lin, Yvonne G.

AU - Mhawech-Fauceglia, Paulette Y.

AU - Shah, Sohrab P.

AU - Huntsman, David G.

AU - Gusev, Alexander

AU - Karlan, Beth Y.

AU - Berman, Benjamin P.

AU - Freedman, Matthew L.

AU - Gayther, Simon A.

AU - Lawrenson, Kate

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The functional consequences of somatic non-coding mutations in ovarian cancer (OC) are unknown. To identify regulatory elements (RE) and genes perturbed by acquired non-coding variants, here we establish epigenomic and transcriptomic landscapes of primary OCs using H3K27ac ChIP-seq and RNA-seq, and then integrate these with whole genome sequencing data from 232 OCs. We identify 25 frequently mutated regulatory elements, including an enhancer at 6p22.1 which associates with differential expression of ZSCAN16 (P = 6.6 × 10-4) and ZSCAN12 (P = 0.02). CRISPR/Cas9 knockout of this enhancer induces downregulation of both genes. Globally, there is an enrichment of single nucleotide variants in active binding sites for TEAD4 (P = 6 × 10-11) and its binding partner PAX8 (P = 2×10-10), a known lineage-specific transcription factor in OC. In addition, the collection of cis REs associated with PAX8 comprise the most frequently mutated set of enhancers in OC (P = 0.003). These data indicate that non-coding somatic mutations disrupt the PAX8 transcriptional network during OC development.

AB - The functional consequences of somatic non-coding mutations in ovarian cancer (OC) are unknown. To identify regulatory elements (RE) and genes perturbed by acquired non-coding variants, here we establish epigenomic and transcriptomic landscapes of primary OCs using H3K27ac ChIP-seq and RNA-seq, and then integrate these with whole genome sequencing data from 232 OCs. We identify 25 frequently mutated regulatory elements, including an enhancer at 6p22.1 which associates with differential expression of ZSCAN16 (P = 6.6 × 10-4) and ZSCAN12 (P = 0.02). CRISPR/Cas9 knockout of this enhancer induces downregulation of both genes. Globally, there is an enrichment of single nucleotide variants in active binding sites for TEAD4 (P = 6 × 10-11) and its binding partner PAX8 (P = 2×10-10), a known lineage-specific transcription factor in OC. In addition, the collection of cis REs associated with PAX8 comprise the most frequently mutated set of enhancers in OC (P = 0.003). These data indicate that non-coding somatic mutations disrupt the PAX8 transcriptional network during OC development.

UR - http://www.scopus.com/inward/record.url?scp=85083843698&partnerID=8YFLogxK

U2 - 10.1038/s41467-020-15951-0

DO - 10.1038/s41467-020-15951-0

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 32332753

AN - SCOPUS:85083843698

SN - 2041-1723

VL - 11

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 2020

ER -

Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this